Abbott's board of directors once again increased the company's dividend – continuing a streak of 45 years. This increase also continues Abbott's inclusion in the prestigious S&P Dividend Aristocrat Index, which tracks companies with long histories of dividend increases.
To find out more, click here to read the news release.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
FOLLOW ABBOTT